A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities (original) (raw)

References

  1. Chambon P . A decade of molecular biology of retinoic acid receptors FASEB J 1996 10: 940–954
    Article CAS Google Scholar
  2. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A . The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus Nature 1990 347: 558–561
    Article Google Scholar
  3. Goddard AD, Borrow J, Freemont P, Solomon E . Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia Science 1991 254: 1371–1374
    Article CAS Google Scholar
  4. Early M, Kakizuka A, Nason-Burchenal K, Martin P, Evans RM, Dmitrovsky E . Transgenic expression of PML/RARA impairs myelopoiesis Proc Natl Acad Sci USA 1996 93: 7900–7904
    Article CAS Google Scholar
  5. He L, Triboli C, Rivi R, Peruzzi D, Pellici PG, Soares V, Cattoretti G, Pandolfi PP . Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice Proc Natl Acad Sci USA 1997 94: 5302–5307
    Article CAS Google Scholar
  6. de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A . The PML-RAR-alpha fusion mRNA generated by t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR Cell 1991 66: 663–674
    Article Google Scholar
  7. Kakizuka A, Miller WH, Umesomo Jr K, Warrell RP, Franckel SR, Murty VS, Dmitrovsky E, Evans RM . Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor, PML Cell 1991 66: 653–674
    Article Google Scholar
  8. Dyck JA, Maul GG, Miller WH, Chen JD, Kakizuka A, Evans RM . A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein Cell 1994 76: 333–343
    Article CAS Google Scholar
  9. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A . Retinoic acid regulatesaberrant nuclear localization of PML-PARα in acute promyelocytic leukemia cells Cell 1994 76: 345–356
    Article CAS Google Scholar
  10. Hong WK, Benner SE, Lippman SM . Evolution of aerodigestive tract 13-_cis_-retinoid acid chemoprevention: the MD Anderson experience Leukemia 1994 8: S33–S37
    PubMed Google Scholar
  11. Peck GL, DiGiovanna JJ . Synthetic retinoids in dermatology. In: MB Sporn, AB Roberts, DS Goodman (eds). The Retinoids, Biology, Chemistry and Medicine, 2nd edn Raven Press: New York 1994 pp 631–657
  12. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhao L, Gu RJ, Wang ZY . Use of all-trans retinoid acid in the treatment of acute promyelocytic leukemia Blood 1988 72: 567–572
    CAS PubMed Google Scholar
  13. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L . All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. Clinical results Blood 1990 76: 1704–1709
    CAS PubMed Google Scholar
  14. Cornic M, Delva L, Guidez F, Balitrand N, Degos L, Chomienne C . Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients Cancer Res 1992 52: 3329–3334
    CAS PubMed Google Scholar
  15. Shao W, Benedetti L, Lamph W, Nervi C, Miller Jr W . A retinoid-resistant acute promyelocytic leukemia subclone express a dominant negative PML-RARA mutation Blood 1997 89: 4282–4289
    CAS PubMed Google Scholar
  16. Kitamura K, Kiyoi H, Yoshida H, Saito H, Ohno R, Naoe T . Mutant AF-2 domain of PML-RARA in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARA and its down-regulation in acute promyelocytic leukemia Leukemia 1997 11: 1950–1956
    Article CAS Google Scholar
  17. Imaizumi M, Suzuki H, Yoshinari M, Sato A, Saito T, Sugawara A, Tshuchiya S, Hatae Y, Fujimoto T, Kakizuka A, Konno T, Linuma K . Mutations in the E-domain of RARA portion of the PML-RARA chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia Blood 1998 92: 374–382
    CAS PubMed Google Scholar
  18. Ding W, Li Y-P, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernick PH, Gallagher E . Leukemic cellular retinoic acid resistance and missense mutations in the PML/RARA fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy Blood 1998 92: 1172–1183
    CAS PubMed Google Scholar
  19. Lanotte M, Martin-Thouvenin V, Najman S, Ballerini P, Valensi F, Berger R . NB4: a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3) Blood 1991 77: 1080–1086
    CAS PubMed Google Scholar
  20. Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner Ph, Berger R, Lanotte M . A retinoid acid ‘resistant’ t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological and molecular features Leukemia 1992 6: 1281–1287
    CAS PubMed Google Scholar
  21. Ruchaud S, Duprez E, Gendron MC, Houge G, Geniesser HG, Jarstoff B, Doskeland SO, Lanotte M . Two distincly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic cell line Proc Natl Acad Sci USA 1994 91: 8428–8432
    Article CAS Google Scholar
  22. Duprez E, Lillehaug JR, Naoe W, Lanotte M . cAMP signal is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RARα Oncogene 1996 12: 241–245
    Google Scholar
  23. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H . Specific enzymatic amplification of DNA in vitro – the polymerase chain reaction Cold Spring Harbor Symp 1986 51: 263–273
    Article CAS Google Scholar
  24. Boddy MN, Howe K, Etkin LD, Solomon E, Freemont PS . PIC-1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukemia Oncogene 1996 13: 971–982
    CAS PubMed Google Scholar
  25. Robertson KA, Emami B, Collins SJ . Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptot ligand-binding domain that confers dominant negative activity Blood 1992 80: 1885–1889
    CAS PubMed Google Scholar
  26. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub MP, Durand B, Lanotte M, Berger R, Chambon P . Structure, localization and transcriptional properties of two classes of retinoid acid receptor a (RAR-α) fusion proteins in acute promyelocytic leukemia (APL). Structural similarities with a new family of oncoproteins EMBO J 1992 11: 629–642
    Article CAS Google Scholar
  27. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D . Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid Nature 1995 378: 681–689
    Article CAS Google Scholar
  28. Lamour FPY, Lardell P, Apfel CM . Analysis of the ligand-biding domain of human retinoic acid receptor α by site-directed mutagenesis Mol Cell Biol 1996 16: 5386–5392
    Article CAS Google Scholar
  29. Pratt M, Kralova J, McBurney MW . A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-non responsive embryonal carcinoma cell Mol Cell Biol 1990 10: 6445–6453
    Article CAS Google Scholar
  30. Tale BF, Grippo JF . Mutagenesis of the ligand binding domain of the human retinoic acid receptor identifies critical residues for 9-cis retinoic acid binding J Biol Chem 1995 270: 20258–20263
    Article Google Scholar
  31. Moras D, Gronemeyer H . The nuclear receptor ligand-binding domain: structure and function Curr Opin Cell Biol 1998 10: 384–391
    Article CAS Google Scholar
  32. Chen JD, Evans RM . A transcriptional co-repressor that interacts with nuclear hormone receptors (see comments) Nature 1995 377: 454–457
    Article CAS Google Scholar
  33. Li Y, Gallagher RE . Retinoic acid-resistant HL60 cells exclusively contain mutant retinoic acid receptor-α Blood 1994 83: 3298–3302
    CAS PubMed Google Scholar
  34. Melnick A, Licht JD . Deconstructing a disease: RARA, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia Blood 1999 93: 3167–3215
    CAS PubMed Google Scholar
  35. Lo Cocco F, Nervi C, Avvisati G, Mandelli F . Acute promyelocytic leukemia: a curable disease Leukemia 1998 12: 1866–1880
    Article Google Scholar
  36. Fanelli M, Minucci S, Gelmetti V, Nervi C, Gambacorti-Passerini C, Pelicci G . Constitutive degradation of PML/RARA through the proteasome pathway mediates retinoic acid resistance Blood 1999 93: 1477–1481
    CAS PubMed Google Scholar
  37. de Thé H, del Mar J, Vivanco-Ruiz M, Tiollais P, Stunnenberg H, Dejean A . Identification of retinoic acid responsive element in the retinoic acid receptor B gene Nature 1990 343: 177–180
    Article Google Scholar
  38. Benoit G, Altucci L, Flexor M, Ruchaud S, Lillchaug J, Raffelsberger H, Gronemeyer H, Lanotte M . RAR-independent RXR signaling induces t(15;17) leukemia cell maturation EMBO J 1999 (in press)

Download references